The Use of Antidepressants, Anxiolytics, and Hypnotics in People with Type 2 Diabetes and Patterns Associated with Use: The Hoorn Diabetes Care System Cohort

Table 3

Multivariate regression analyses determining patient characteristics of antidepressants, anxiolytics, and hypnotics use versus no antidepressants, anxiolytics, and hypnotics use.

	Univariate OR (95% CI)	Multivariate OR (95% CI)
Sex (female)	2.29 (2.02–2.61	2.37 (2.08–2.70)
Age (years)	1.02 (1.01–1.02
HbA1c level (mmol/mol)	0.98 (0.92–1.04)
Comorbidity (myocardial infarction, transient ischaemic attack, stroke)	1.49 (1.28–1.74	1.64 (1.40–1.93)
BMI (kg/m^2)	1.02 (1.01–1.03
Ethnicity (non-Caucasian)	0.63 (0.55–0.71)	0.65 (0.57–0.74)

Estimated are odds ratios (OR) with 95% confidence interval. indicates a significant association ( < 0.05). The univariate model shows the determinants with values <0.05. The multivariate model shows the final model after backward selection, including variables with values <0.05.